KIR2DL4/CD158d Antikörper (AA 51-150) (Cy5.5)
Kurzübersicht für KIR2DL4/CD158d Antikörper (AA 51-150) (Cy5.5) (ABIN748468)
Target
Alle KIR2DL4/CD158d (KIR2DL4) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 51-150
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CD158
-
Isotyp
- IgG
-
-
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 4 (KIR2DL4) antibody
KIR2DL4 Reaktivität: Human FACS, IP, ICC Wirt: Maus Monoclonal mAb 33 unconjugated
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 4 (KIR2DL4) (AA 22-120) antibodyKIR2DL4 Reaktivität: Human FACS, ELISA Wirt: Maus Monoclonal 2E3E12 unconjugated
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 4 (KIR2DL4) antibodyKIR2DL4 Reaktivität: Human FACS, IP, ICC, Func Wirt: Maus Monoclonal mAb 33 unconjugated
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 4 (KIR2DL4) (AA 296-323), (C-Term) antibodyKIR2DL4 Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB23034 unconjugated
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 4 (KIR2DL4) (Center) antibodyKIR2DL4 Reaktivität: Human WB, IHC (p), ICC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 4 (KIR2DL4) antibody (APC)KIR2DL4 Reaktivität: Human FACS Wirt: Maus Monoclonal mAb 33 APC
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 4 (KIR2DL4) (AA 1-377) antibodyKIR2DL4 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 4 (KIR2DL4) antibody (PE)KIR2DL4 Reaktivität: Human FACS Wirt: Maus Monoclonal mAb 33 PE
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 4 (KIR2DL4) (AA 302-332), (C-Term) antibodyKIR2DL4 Reaktivität: Human WB, FACS, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 4 (KIR2DL4) antibodyKIR2DL4 Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- KIR2DL4/CD158d (KIR2DL4) (Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 4 (KIR2DL4))
-
Hintergrund
-
Synonyms: G9P, CD158D, KIR103, KIR103AS, KIR-103AS, Killer cell immunoglobulin-like receptor 2DL4, CD158 antigen-like family member D, Killer cell inhibitory receptor 103AS, MHC class I NK cell receptor KIR103AS, KIR2DL4
Background: Receptor on natural killer (NK) cells for HLA-C alleles. Inhibits the activity of NK cells thus preventing cell lysis.
-
Gen-ID
- 3805
-
UniProt
- Q99706
Target
-
